Why Exact Sciences Shares Are Soaring 11.6% Today
After the company reported better-than-expected top- and bottom-line third-quarter results today, shares of Exact Sciences (NASDAQ: EXAS) are jumping 11.6% at 12:30 p.m. EDT.
As many as 20 million Americans between the ages of 50 and 74 are not getting colon cancer screening as often as recommended, and as a result, many patients are diagnosed with advanced colon cancer that could have been detected at an earlier stage, when chances of survival are higher.
IMAGE SOURCE: EXACT SCIENCES.
Source: Fool.com
Exact Sciences Aktie
60,89 €
3,06 %
Mehrere Buy-Einschätzungen geben Exact Sciences den Vorteil, ohne Sell-Einschätzungen.
Das Community-Kursziel von 76 € für Exact Sciences deutet auf eine deutliche Steigerung um mehr als 20% gegenüber dem aktuellen Kurs von 60.89 € hin.
